# A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50

> **NCT03562923** · PHASE3 · UNKNOWN · sponsor: **Amneal Ireland Limited** · enrollment: 1204 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Test Product
- **DRUG:** Reference Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03562923
- **Lead sponsor:** Amneal Ireland Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10
- **Primary completion:** 2019-05
- **Final completion:** 2019-06
- **Target enrollment:** 1204 (ESTIMATED)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03562923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03562923, "A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03562923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*